BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 6, 2007
View Archived Issues
Lilly Plans Hypnion Takeover, Getting Phase II Insomnia Drug
Less than two months after Phase II success with its insomnia drug, privately held Hypnion Inc. is being taken over by Eli Lilly and Co. for undisclosed terms. (BioWorld Today)
Read More
Memory's MEM 1003 Misses In Bipolar Trial; AD Study Ongoing
Read More
VentiRx Raises $26.6M, Plans For Acquisition Of TLR Platform
Read More
Calistoga Secures $21M Series A Investment For p110 Delta Work
Read More
Clinic Roundup
Read More
Other News To Note
Read More